X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Benign Prostatic Hyperplasia Companies

This report lists the top Benign Prostatic Hyperplasia companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Benign Prostatic Hyperplasia industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Benign Prostatic Hyperplasia Top Companies

  1. Abbvie

  2. Eli Lilly and Company

  3. Merck

  4. Boehringer Ingelheim

  5. Astellas Pharma

*Disclaimer: Top companies sorted in no particular order

Benign Prostatic Hyperplasia Market Major Players

Benign Prostatic Hyperplasia Market Concentration

Benign Prostatic Hyperplasia  Market Concentration

Benign Prostatic Hyperplasia Company List

                            • Allergan PLC

                            • Astellas Pharma Inc.

                            • Boehringer Ingelheim

                            • Eli Lilly and Company

                            • GlaxoSmithKline PLC

                            • Nymox Pharmaceutical Corporation

                            • Pfizer Inc

                            • Sanofi

                            • Sophiris Bio Corp

                            • Teva Pharmaceutical Industries Limited


                        Specific to Benign Prostatic Hyperplasia Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Benign Prostatic Hyperplasia Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)